Enfusion Stock Price Prediction

ENFN Stock  USD 9.38  0.08  0.86%   
As of today, The relative strength indicator of Enfusion's share price is at 52 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Enfusion, making its price go up or down.

Oversold Vs Overbought

52

 
Oversold
 
Overbought
The successful prediction of Enfusion's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Enfusion, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Enfusion's stock price prediction:
Quarterly Earnings Growth
(0.27)
EPS Estimate Next Quarter
0.06
EPS Estimate Current Year
0.21
EPS Estimate Next Year
0.29
Wall Street Target Price
9.84
Using Enfusion hype-based prediction, you can estimate the value of Enfusion from the perspective of Enfusion response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Enfusion to buy its stock at a price that has no basis in reality. In that case, they are not buying Enfusion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Enfusion after-hype prediction price

    
  USD 9.36  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Enfusion Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
Intrinsic
Valuation
LowRealHigh
7.659.6211.61
Details
Naive
Forecast
LowNextHigh
7.689.6711.65
Details
9 Analysts
Consensus
LowTargetHigh
9.2510.1711.29
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.040.050.06
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Enfusion. Your research has to be compared to or analyzed against Enfusion's peers to derive any actionable benefits. When done correctly, Enfusion's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Enfusion.

Enfusion After-Hype Price Prediction Density Analysis

As far as predicting the price of Enfusion at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enfusion or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enfusion, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Enfusion Estimiated After-Hype Price Volatility

In the context of predicting Enfusion's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enfusion's historical news coverage. Enfusion's after-hype downside and upside margins for the prediction period are 7.38 and 11.34, respectively. We have considered Enfusion's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
9.38
9.36
After-hype Price
11.34
Upside
Enfusion is not too volatile at this time. Analysis and calculation of next after-hype price of Enfusion is based on 3 months time horizon.

Enfusion Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Enfusion is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enfusion backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enfusion, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
1.97
  0.02 
 0.00  
10 Events / Month
11 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
9.38
9.36
0.21 
3,283  
Notes

Enfusion Hype Timeline

Enfusion is currently traded for 9.38. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. Enfusion is forecasted to decline in value after the next headline, with the price expected to drop to 9.36. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.21%, whereas the daily expected return is currently at 0.27%. The volatility of related hype on Enfusion is about 98500.0%, with the expected price after the next announcement by competition of 9.38. About 96.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.35. Enfusion had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days.
Check out Enfusion Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

Enfusion Related Hype Analysis

Having access to credible news sources related to Enfusion's direct competition is more important than ever and may enhance your ability to predict Enfusion's future price movements. Getting to know how Enfusion's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enfusion may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MODNModel N(0.04)8 per month 0.29  0.0002  1.01 (0.50) 10.58 
ONTFON24 Inc(0.11)8 per month 1.84  0.01  3.50 (2.64) 10.14 
PYCRPaycor HCM 0.44 10 per month 1.18  0.18  3.05 (2.59) 12.90 
PWSCPowerschool Holdings 0.01 11 per month 0.00 (1.21) 0.18 (0.13) 0.71 
ETWOE2open Parent Holdings 0.04 8 per month 0.00 (0.11) 3.87 (5.33) 25.44 
MNTVMomentive Global(0.02)8 per month 0.00  0.13  0.43 (0.21) 20.63 
BRZEBraze Inc 0.75 12 per month 0.00 (0.1) 3.67 (4.84) 23.07 
FRSHFreshworks 0.14 9 per month 1.35  0.12  3.67 (2.77) 7.44 
CWANClearwater Analytics Holdings(0.75)8 per month 1.02  0.15  3.05 (2.60) 6.13 
LAWCS Disco LLC 0.01 11 per month 1.84 (0.0002) 3.63 (3.07) 10.88 
PROPROS Holdings 0.31 9 per month 2.91  0.02  6.36 (5.04) 13.99 
MIXTMix Telemats 0.00 0 per month 0.00 (0.13) 3.52 (3.34) 12.12 
MLNKMeridianlink 0.08 12 per month 2.26 (0.02) 3.17 (3.18) 14.62 
BLKBBlackbaud(0.84)9 per month 2.85  0  2.88 (1.73) 18.39 
CVTCvent Holding Corp 0.01 12 per month 0.00 (0.78) 0.24 (0.24) 1.07 

Enfusion Additional Predictive Modules

Most predictive techniques to examine Enfusion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enfusion using various technical indicators. When you analyze Enfusion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Enfusion Predictive Indicators

The successful prediction of Enfusion stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enfusion, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enfusion based on analysis of Enfusion hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enfusion's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enfusion's related companies.
 2021 2023 2024 (projected)
Dividend Yield0.0023910.0027490.003434
Price To Sales Ratio12.294.94.66

Story Coverage note for Enfusion

The number of cover stories for Enfusion depends on current market conditions and Enfusion's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enfusion is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enfusion's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Enfusion Short Properties

Enfusion's future price predictability will typically decrease when Enfusion's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enfusion often depends not only on the future outlook of the potential Enfusion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enfusion's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding129.4 M
Cash And Short Term Investments35.6 M
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:
Check out Enfusion Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Earnings Share
0.04
Revenue Per Share
2.155
Quarterly Revenue Growth
0.154
Return On Assets
0.0592
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.